Skip to main content
Skip to section navigation
Skip to footer
Stock Information
chevron_left
Back to VyomeTx.com
Investors
News & Events
Press Releases
IR Calendar
Presentations
Email Alerts
In the News
Company Information
Company Profile
Executive Team
Contacts
FAQ
Financial Information
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote & Chart
Historical Data
Analyst Coverage
SEC Filings
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Governance Overview
Board of Directors
Board Committees
Advisory Board
Governance Documents
Stock Information
chevron_left
Back to VyomeTx.com
In the News
News & Events
News & Events
Press Releases
IR Calendar
Presentations
Email Alerts
In the News
Sep 4, 2025
Vyome’s VT-1953 shows significant reduction in cancer wound odor
Aug 22, 2025
Reverse Merger Offers Vyome Cost Effective Route to Go Public
Aug 21, 2025
Vyome partners with Embryyo to enter AI-enabled medical device market
Aug 16, 2025
Vyome lists on Nasdaq as HIND after ReShape merger
Aug 15, 2025
Vyome to leverage US-India ties to tackle $100B immuno-inflammatory market
Aug 13, 2025
Vyome Therapeutics to list on Nasdaq as HIND after ReShape merger
rss_feed
RSS
Previous Page
arrow_back
Page
1
Page
2
Page
3
Select a page
Page 1
Page 2
Page 3
email
Email Alerts
location_city
Company Profile
contact_page
Contacts
rss_feed
RSS News Feed
